on 13 Nov 2024
Last Applicant/ Owned by
Novartis AG
CH-4002 Basel
CH
Serial Number
2262663 filed on 29th Apr 2023
Trademark usage description
préparations pharmaceutiques pour la prévention et le traitement du système nerveux central, à savoir les infections du système nerveux central, les m Read More12
2262663
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 42 on 13th Nov 2024 | Advertised |
Submitted for opposition 26 on 16th Oct 2024 | Approved |
Submitted for opposition 27 on 16th Oct 2024 | Approval Notice Sent |
Submitted for opposition 22 on 29th Aug 2024 | Search Recorded |
Submitted for opposition 256 on 08th Apr 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 08th Jun 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 1 on 07th Jun 2023 | Created |
Submitted for opposition 31 on 07th Jun 2023 | Formalized |
Submitted for opposition 30 on 29th Apr 2023 | Filed |
Submitted for opposition 228 on 29th Apr 2023 | International Registration |